Asia-Pacific trade increased as hazard sentiment enhances, essential U.S. inflation facts ahead

Pedestrians walk in front of an digital quotation board exhibiting stock costs of the Tokyo Stock Exchange in Tokyo on March 7, 2022.

Kazuhiro Nogi | AFP through Getty Illustrations or photos

Shares in the Asia-Pacific rose Monday on improved threat sentiment.

The Nikkei 225 in Japan gained 1.26% in early trade, though the Topix index innovative .92%.

Australia’s S&P/ASX 200 also added .92%. MSCI’s broadest index of Asia-Pacific shares outside Japan ticked .18% bigger.

Mainland China, Hong Kong and South Korea marketplaces are shut for a holiday break. The U.S. is established to release its purchaser cost index for August later in the week.

Source

Finland’s IQM to become one of Europe’s first listed quantum companies at .8 billion valuation

World

Finland’s IQM to become one of Europe’s first listed quantum companies at $1.8 billion valuation

February 23, 2026

European startup IQM is aiming to build powerful quantum computers to rival the likes of Google and IBM. IQM Finland-based quantum computing startup IQM announced plans Monday to become one of Europe’s first publicly listed companies in the sector. IQM will merge with special purpose acquisition company (SPAC), Real Asset Acquisition Corp. (RAAQ) as part […]

World

Treasury yields hold steady as investors weigh new Trump tariffs

February 23, 2026

U.S. Treasury yields were little changed to start the week as investors weighed President Donald Trump’s latest tariffs, after the Supreme Court struck down much of the duties on Friday. At 6:03 a.m. ET, the 10-year Treasury yield was down 1 basis point at 4.075%. The 30-year Treasury bond yield was also less than 1 basis point lower […]

World

Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly’s in trial

February 23, 2026

Novo Nordisk stock fell over 10% Monday after it said its next-generation weight loss drug didn’t meet its primary target. The drug, CagriSema, didn’t achieve its primary endpoint of demonstrating non-inferiority on weight loss when compared to Eli Lilly‘s rival drug tirzepatide after 84 weeks, Novo said in a statement Monday morning. Eli Lilly‘s stock […]